---
figid: PMC6626719__WJG-25-3151-g003
figtitle: Aberrant activation of the Wnt/Beta-catenin signaling pathway in hepatocellular
  carcinoma
organisms:
- NA
pmcid: PMC6626719
filename: WJG-25-3151-g003.jpg
figlink: /pmc/articles/PMC6626719/figure/F3/
number: F3
caption: 'Aberrant activation of the Wnt/β-catenin signaling pathway in hepatocellular
  carcinoma. A: Wnt signaling is inactive in the absence of Wnt ligands (OFF); B:
  Wnt signaling can be activated by various molecules in HCC (ON). HBV and HCV can
  active Wnt/β-catenin signaling by activating TCF or inhibiting GSK3β; HBx can silence
  SFRPs to activate Wnt signaling; LncTCF7 triggers Wnt7a and TCF7 expression to activate
  Wnt signaling. Lines ending with arrows or bars indicate activating or inhibitory
  effects, respectively. HIF1α: Hypoxia-inducible factor 1α; LEF: Lymphoid enhancer-binding
  factor; LRP: Low-density lipoprotein receptor-related protein; TCF: T cell factor;
  FZD: Frizzled; E-cad: E-cadherin; SFRPs: Secreted frizzled-related proteins; CTGF:
  Connective tissue growth factor; WISP2: Wnt1 inducible signaling pathway protein
  2.'
papertitle: 'Hepatocellular carcinoma: Mechanisms of progression and immunotherapy.'
reftext: Yu Jiang, et al. World J Gastroenterol. 2019 Jul 7;25(25):3151-3167.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9585183
figid_alias: PMC6626719__F3
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC6626719__F3
ndex: f827498b-dec1-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6626719__WJG-25-3151-g003.html
  '@type': Dataset
  description: 'Aberrant activation of the Wnt/β-catenin signaling pathway in hepatocellular
    carcinoma. A: Wnt signaling is inactive in the absence of Wnt ligands (OFF); B:
    Wnt signaling can be activated by various molecules in HCC (ON). HBV and HCV can
    active Wnt/β-catenin signaling by activating TCF or inhibiting GSK3β; HBx can
    silence SFRPs to activate Wnt signaling; LncTCF7 triggers Wnt7a and TCF7 expression
    to activate Wnt signaling. Lines ending with arrows or bars indicate activating
    or inhibitory effects, respectively. HIF1α: Hypoxia-inducible factor 1α; LEF:
    Lymphoid enhancer-binding factor; LRP: Low-density lipoprotein receptor-related
    protein; TCF: T cell factor; FZD: Frizzled; E-cad: E-cadherin; SFRPs: Secreted
    frizzled-related proteins; CTGF: Connective tissue growth factor; WISP2: Wnt1
    inducible signaling pathway protein 2.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SETD2
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - LRP6
  - LRP5
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - CDH1
  - CTNNB1
  - ADAR
  - DVL1P1
  - CSNK1A1
  - KRT1
  - CSNK1A1L
  - APC
  - PROC
  - GSK3B
  - AXIN1
  - AXIN2
  - HNF4A
  - CCND1
  - CCN5
  - CAD
  - DFFB
  - ACOD1
  - GSTM1
  - CCN2
  - TCE
  - ARS
---
